课题基金 / 基金详情

EVALUATION OF DRUG METABOLIZING STATUS BY CARBON DIOXIDE BREATH TESTS

EVALUATION OF DRUG METABOLIZING STATUS BY CARBON DIOXIDE BREATH TESTS
通过二氧化碳呼气试验评价药物代谢状态
批准号:
3822962
负责人:
E A LANE
金额:
$0.0万
依托单位国家:
美国
项目类别:
财政年份:
--
资助国家:
美国
项目状态:
未结题
起止时间:
至

项目摘要

项目成果

E A LANE的其他基金

相似基金

相关文献

中文摘要
翻译
碳源药物美沙西丁在人体内的总处置 已经对二氧化碳呼气测试进行了调查。血浆和尿液浓度 美沙西丁及其代谢物对乙酰氨基酚、对乙酰氨基酚葡萄糖 和对乙酰氨基酚的测定采用高效液体法。 层析法。呼气中的13C-二氧化碳是由 同位素比值质谱学。美沙西丁剂量的分数 脱甲基化是根据清除概念计算的,也是从 单次给药后尿代谢物的测定 对乙酰氨基酚。结果发现,100%的美沙星剂量是 脱甲基化为对乙酰氨基酚,但只有51%的甲基碳原子是 以二氧化碳的形式在呼气中消除。
英文摘要
The total disposition in man of methacetin, a drug used in the carbon dioxide breath test has been investigated. Plasma and urine concentrations of methacetin and its metabolites, acetaminophen, acetaminophen glucoronide and acetaminophen sulfate were measured by high performance liquid chromatography. The 13C-carbon dioxide in expired breath was measured by isotope ratio mass spectrometry. The fraction of the methacetin dose demthylated was calculated according to clearance concepts and also from measurement of urinary metabolites after a single dose each of methacin and acetaminophen. It was found that 100% of the methacin dose was demethylated to acetaminophen, but only 51% of the methyl carbon atoms were eliminated in breath as carbon dioxide.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
APPLICATION OF PHARMACOKINETICS TO NEUROTRANSMITTER DISPOSITION
EVALUATION OF DRUG METABOLIZING STATUS BY CARBON DIOXIDE BREATH TESTS
ACETYLATION PHENOTYPE OF ALCOHOLICS
APPLICATION OF PHARMACOKINETICS TO NEUROTRANSMITTER DISPOSITION
海外基金